Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses. . . . → Read More: Trial Shows Broad Coronavirus Immune Response
|
|||||
       |
 Comments are closed  New products  biomedical, biotechnology, Canada, clinical trials, Covid-19, health care, life sciences, pharmaceuticals 
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, Covid-19, Europe, genomics, grant, licensing, life sciences, nanotechnology, preclinical, university 
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments. . . . → Read More: Chip Device Simulates Coronavirus Gut Symptoms Comments are closed New products biomedical, Covid-19, engineering, life sciences, medical device, physical sciences, preclinical, university 
Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range Comments are closed New products agriculture, biomedical, biotechnology, chemistry, Covid-19, genomics, life sciences, manufacturing, patent, pharmaceuticals, physical sciences, preclinical, university 
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, China, clinical trials, Covid-19, Europe, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds. . . . → Read More: Coronavirus Antibody Maker Raises $80M in New Funds Comments are closed Finance, New products biomedical, biotechnology, Covid-19, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections. . . . → Read More: Start-Up Developing Coronavirus Antibodies, Raises $50M Comments are closed Finance, New products biomedical, biotechnology, Covid-19, entrepreneurs, equity, investment, life sciences, pharmaceuticals, preclinical, university, venture capital 
While the pandemic is an urgent global problem, the chart makes clear where the threat from the disease is most immediate. . . . → Read More: Infographic – National Coronavirus Case Severity One comment - (Comments are closed) Business conditions biomedical, Covid-19, health care, life sciences, statistics, university 
An industry-government collaboration aims to advance and produce vaccines against the 2019 novel coronavirus outbreak in China and elsewhere. . . . → Read More: Janssen, BARDA Partner on Coronavirus Vaccine Comments are closed Joint ventures/collaborations biomedical, biotechnology, China, Covid-19, health care, life sciences, manufacturing, pharmaceuticals The emergence of the novel coronavirus has created even more uncertainty about doing business in China and throughout Asia. . . . → Read More: Planning for the Post-Coronavirus Era |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts